RESUMO
Neutrophils are implicated in the pathogenesis of many diseases involving inflammation. Neutrophils are also critical to host defence and have a key role in the innate immune response to infection. Despite their efficiencies against a wide range of pathogens however, their ability to contain and combat Mycobacterium tuberculosis (Mtb) in the lung remains uncertain and contentious. The host response to Mtb infection is very complex, involving the secretion of various cytokines and chemokines from a wide variety of immune cells, including neutrophils, macrophages, monocytes, T cells, B cells, NK cells and dendritic cells. Considering the contributing role neutrophils play in the advancement of many diseases, understanding how an inflammatory microenvironment affects neutrophils, and how neutrophils interact with other immune cells, particularly in the context of the infected lung, may aid the design of immunomodulatory therapies. In the current review, we provide a brief overview of the mechanisms that underpin pathogen clearance by neutrophils and discuss their role in the context of Mtb and non-Mtb infection. Next, we examine the current evidence demonstrating how neutrophils interact with a range of human and non-human immune cells and how these interactions can differentially prime, activate and alter a repertoire of neutrophil effector functions. Furthermore, we discuss the metabolic pathways employed by neutrophils in modulating their response to activation, pathogen stimulation and infection. To conclude, we highlight knowledge gaps in the field and discuss plausible novel drug treatments that target host neutrophil metabolism and function which could hold therapeutic potential for people suffering from respiratory infections.
Assuntos
Neutrófilos , Tuberculose , Quimiocinas/metabolismo , Citocinas/metabolismo , Humanos , Pulmão/metabolismoRESUMO
BACKGROUND: Barrett's esophagus follows the classic step-wise progression of metaplasia-dysplasia-adenocarcinoma. While Barrett's esophagus is a leading known risk factor for esophageal adenocarcinoma, the pathogenesis of this disease sequence is poorly understood. Mitochondria are highly susceptible to mutations due to high levels of reactive oxygen species (ROS) coupled with low levels of DNA repair. The timing and levels of mitochondria instability and dysfunction across the Barrett's disease progression is under studied. METHODS: Using an in-vitro model representing the Barrett's esophagus disease sequence of normal squamous epithelium (HET1A), metaplasia (QH), dysplasia (Go), and esophageal adenocarcinoma (OE33), random mitochondrial mutations, deletions and surrogate markers of mitochondrial function were assessed. In-vivo and ex-vivo tissues were also assessed for instability profiles. RESULTS: Barrett's metaplastic cells demonstrated increased levels of ROS (p < 0.005) and increased levels of random mitochondrial mutations (p < 0.05) compared with all other stages of the Barrett's disease sequence in-vitro. Using patient in-vivo samples, Barrett's metaplasia tissue demonstrated significantly increased levels of random mitochondrial deletions (p = 0.043) compared with esophageal adenocarcinoma tissue, along with increased expression of cytoglobin (CYGB) (p < 0.05), a gene linked to oxidative stress, compared with all other points across the disease sequence. Using ex-vivo Barrett's metaplastic and matched normal patient tissue explants, higher levels of cytochrome c (p = 0.003), SMAC/Diablo (p = 0.008) and four inflammatory cytokines (all p values <0.05) were secreted from Barrett's metaplastic tissue compared with matched normal squamous epithelium. CONCLUSIONS: We have demonstrated that increased mitochondrial instability and markers of cellular and mitochondrial stress are early events in the Barrett's disease sequence.
Assuntos
Adenocarcinoma/genética , Esôfago de Barrett/genética , Regulação Neoplásica da Expressão Gênica , Metaplasia/genética , Mitocôndrias/genética , Mutação , Adenocarcinoma/metabolismo , Esôfago de Barrett/metabolismo , Linhagem Celular , Linhagem Celular Tumoral , Citocromos c/metabolismo , Citoglobina , Citocinas/metabolismo , Progressão da Doença , Ensaio de Imunoadsorção Enzimática , Esôfago/metabolismo , Esôfago/patologia , Globinas/genética , Globinas/metabolismo , Humanos , Mediadores da Inflamação/metabolismo , Metaplasia/metabolismo , Mitocôndrias/metabolismo , Proteínas Mitocondriais/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de RiscoRESUMO
OBJECTIVES: This study examines the relationship between synovial hypoxia and cellular bioenergetics with synovial inflammation. METHODS: Primary rheumatoid arthritis synovial fibroblasts (RASF) were cultured with hypoxia, dimethyloxalylglycine (DMOG) or metabolic intermediates. Mitochondrial respiration, mitochondrial DNA mutations, cell invasion, cytokines, glucose and lactate were quantified using specific functional assays. RASF metabolism was assessed by the XF24-Flux Analyzer. Mitochondrial structural morphology was assessed by transmission electron microscopy (TEM). In vivo synovial tissue oxygen (tpO2 mmHg) was measured in patients with inflammatory arthritis (n=42) at arthroscopy, and markers of glycolysis/oxidative phosphorylation (glyceraldehyde 3-phosphate dehydrogenase (GAPDH), PKM2, GLUT1, ATP) were quantified by immunohistology. A subgroup of patients underwent contiguous MRI and positron emission tomography (PET)/CT imaging. RASF and human dermal microvascular endothelial cells (HMVEC) migration/angiogenesis, transcriptional activation (HIF1α, pSTAT3, Notch1-IC) and cytokines were examined in the presence of glycolytic inhibitor 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO). RESULTS: DMOG significantly increased mtDNA mutations, mitochondrial membrane potential, mitochondrial mass, reactive oxygen species and glycolytic RASF activity with concomitant attenuation of mitochondrial respiration and ATP activity (all p<0.01). This was coupled with altered mitochondrial morphology. Hypoxia-induced lactate levels (p<0.01), which in turn induced basic fibroblast growth factor (bFGF) secretion and RASF invasiveness (all p<0.05). In vivo glycolytic markers were inversely associated with synovial tpO2 levels <20â mmâ Hg, in contrast ATP was significantly reduced (all p<0.05). Decrease in GAPDH and GLUT1 was paralleled by an increase in in vivo tpO2 in tumour necrosis factor alpha inhibitor (TNFi) responders. Novel PET/MRI hybrid imaging demonstrated close association between metabolic activity and inflammation. 3PO significantly inhibited RASF invasion/migration, angiogenic tube formation, secretion of proinflammatory mediators (all p<0.05), and activation of HIF1α, pSTAT3 and Notch-1IC under normoxic and hypoxic conditions. CONCLUSIONS: Hypoxia alters cellular bioenergetics by inducing mitochondrial dysfunction and promoting a switch to glycolysis, supporting abnormal angiogenesis, cellular invasion and pannus formation.
Assuntos
Artrite Reumatoide/fisiopatologia , Metabolismo Energético/fisiologia , Fibroblastos/metabolismo , Aminoácidos Dicarboxílicos/metabolismo , Movimento Celular/fisiologia , Células Cultivadas , Citocinas/análise , DNA Mitocondrial/metabolismo , Glucose/análise , Humanos , Hipóxia/metabolismo , Articulações/metabolismo , Ácido Láctico/análise , Mitocôndrias/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Membrana Sinovial/citologiaRESUMO
In Barrett associated tumorigenesis, oxidative phosphorylation and glycolysis are reprogrammed early in the disease sequence and act mutually to promote disease progression. However, the link between energy metabolism and its connection with other central cellular processes within the Barrett microenvironment is unknown. The aim of this study was to examine the relationship between metabolism (ATP5B/GAPDH), hypoxia (HIF1α), inflammation (IL1ß/SERPINA3), p53 and obesity status using in-vivo and ex-vivo models of Barrett oesophagus. At the protein level, ATP5B (r = 0.71, P < 0.0001) and p53 (r = 0.455, P = 0.015) were found to be strongly associated with hypoxia. In addition, levels of ATP5B (r = 0.53, P = 0.0031) and GAPDH (r = -0.39, P = 0.0357) were positively associated with p53 expression. Moreover, we demonstrate that ATP5B (r = 0.8, P < 0.0001) and GAPDH (r = 0.43, P = 0.022) were positively associated with IL1ß expression. Interestingly, obesity was negatively associated with oxidative phosphorylation (r = -0.6016, P = 0.0177) but positively associated with glycolysis (r = 0.743, P = 0.0015). Comparable correlations were exhibited in the ex-vivo explant tissue between metabolism, p53, hypoxia, inflammation and angiogenesis (P < 0.05). We have shown that metabolism is closely linked with many cellular processes in the Barrett tissue microenvironment.
Assuntos
Esôfago de Barrett/metabolismo , Comunicação Celular , Microambiente Celular , Esôfago/metabolismo , Idoso , Esôfago de Barrett/patologia , Esôfago de Barrett/fisiopatologia , Biomarcadores/metabolismo , Hipóxia Celular , Linhagem Celular , Esôfago/irrigação sanguínea , Esôfago/patologia , Feminino , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Glicólise , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Inflamação/metabolismo , Mediadores da Inflamação/metabolismo , Interleucina-1beta/metabolismo , Masculino , Pessoa de Meia-Idade , ATPases Mitocondriais Próton-Translocadoras/metabolismo , Neovascularização Patológica , Obesidade/metabolismo , Fosforilação Oxidativa , Estudos Prospectivos , Serpinas/metabolismo , Transdução de Sinais , Proteína Supressora de Tumor p53/metabolismoRESUMO
Contemporary clinical management of Barrett's oesophagus has highlighted the lack of accurate predictive markers of disease progression to oesophageal cancer. This study aims to examine alterations in mitochondrial energy metabolism profiles across the entire disease progression sequence in Barrett's oesophagus. An in-vitro model was used to screen 84 genes associated with mitochondrial energy metabolism. Three energy metabolism genes (ATP12A, COX4I2, COX8C) were significantly altered across the in-vitro Barrett's disease sequence. In-vivo validations across the Barrett's sequence demonstrated differential expression of these genes. Tissue microarrays demonstrated significant alterations in both epithelial and stromal oxidative phosphorylation (ATP5B and Hsp60) and glycolytic (PKM2 and GAPDH) protein markers across the in-vivo Barrett's sequence. Levels of ATP5B in sequential follow up surveillance biopsy material segregated Barrett's non progressors and progressors to HGD and cancer. Utilising the Seahorse XF24 flux analyser, in-vitro Barrett's and adenocarcinoma cells exhibited altered levels of various oxidative parameters. We show for the first time that mitochondrial energy metabolism is differentially altered across the metaplasia-dysplasia-adenocarcinoma sequence and that oxidative phosphorylation profiles have predictive value in segregating Barrett's non progressors and progressors to adenocarcinoma.
Assuntos
Adenocarcinoma/metabolismo , Esôfago de Barrett/metabolismo , Regulação Neoplásica da Expressão Gênica , Mitocôndrias/metabolismo , Esôfago de Barrett/patologia , Biópsia , Linhagem Celular Tumoral , Progressão da Doença , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Metabolismo Energético , Perfilação da Expressão Gênica , Glicólise , ATPase Trocadora de Hidrogênio-Potássio/metabolismo , Humanos , Metaplasia/metabolismo , Análise de Sequência com Séries de Oligonucleotídeos , Oxigênio/química , FosforilaçãoRESUMO
The most significant transformation of health-care delivery and the health insurance industry is under way in the United States. It will change forever, and for the better, the way the delivery and financing of our nation's health-care is structured. We are witnessing the industrialization and consolidation of what was once a fragmented cottage industry. The new system--we call it wave III--will result in the re-establishment of the physician/providers as the key decision makers in our health-care system of the future. In this next phase of change, organized groups of physicians and hospitals will replace the current HMO insurance structure. This Third Wave will witness the integration of technology, managerial skills, marketing, sales, and negotiating acumen that were previously in the domain of health insurance companies (HMOs) into a delivery system where physicians and hospitals become partners focusing their coordinated efforts in managing health-care and the associated premiums.
Assuntos
Prestação Integrada de Cuidados de Saúde/tendências , Programas de Assistência Gerenciada/tendências , Gestão de Riscos/tendências , Prestação Integrada de Cuidados de Saúde/economia , Previsões , Humanos , Seguro Saúde/economia , Seguro Saúde/tendências , Programas de Assistência Gerenciada/economia , Gestão de Riscos/economia , Estados UnidosRESUMO
The bifunctional reagent N,N'-p-phenylenedimaleimide (PDM) is being used in an attempt to measure distances between specific side chains in adjacent monomers within F-actin. [14C]PDM was synthesized and was used to crosslink F-actin. Uncrosslinked actin was removed by gel filtration, and, from an arginine-specific tryptic digest of the covalently crosslinked dimers and higher oligomers, one radioactive crosslinked peptide was obtained in high yield. Amino acid composition and sequence analysis indicated that it comprises residues 184-196 of one monomer and 373-375 of an adjacent actin molecule, bridged by PDM through Cys-374 and Lys-191. Thus, these groups are shown to be 1.2-1.4 nm apart in adjacent actin monomers in F-actin. This information may be crucial in establishing the orientation of actin monomers within F-actin.
Assuntos
Actinas , Cisteína , Lisina , Maleimidas , Sequência de Aminoácidos , Animais , Cromatografia em Gel , Cromatografia Líquida de Alta Pressão , Reagentes de Ligações Cruzadas , Substâncias Macromoleculares , CoelhosRESUMO
Following in vitro stimulation with phytohaemagglutinin, lymphocytes from coeliac patients transformed less than those from control subjects. Neither gliadin nor detoxified gliadin stimulated lymphocyte transformation in patients with adult coeliac disease, but depressed transformation in lymphocytes from normal subjects and from patients on a gluten-free diet.
Assuntos
Doença Celíaca/imunologia , Gliadina/administração & dosagem , Ativação Linfocitária , Proteínas de Plantas/administração & dosagem , Reações Antígeno-Anticorpo , Doença Celíaca/dietoterapia , Ensaios Clínicos como Assunto , Humanos , Fito-Hemaglutininas/uso terapêuticoRESUMO
1. Gliadin from which carbohydrate was removed by treatment with carbohydrase from Aspergillus niger was fed to three coeliac patients in remission. 2. Xylose absorption, mucosal morphology and brush-border enzymes were used to assess the toxicity of the carbohydrase-treated gliadin. 3. Gliadin treated with carbohydrases did not damage the intestinal mucosa of the coeliac patients. 4. The primary structure of the gliadin proteins was not altered by the enzyme treatment.